drugset / Trial / NCT02199574
Pharmacokinetic Evaluation of EXPAREL in Adults Undergoing Tonsillectomy
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to characterize the pharmacokinetic (PK) profile of a single dose of EXPAREL (133 mg/10 mL) administered intraoperatively per normal infiltration for prolonged analgesia in 12 adult subjects undergoing tonsillectomy with or without removal of the adenoids.
Timeline
- Start
- 2014-08
- Primary completion
- 2015-04
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 133 mg | Other |
Indications
No indication recorded.